December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

3.680 +0.250 (+7.29%)
Streaming Delayed Price Updated: 10:50 AM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Why U.S. Stocks Are Trading Mixed; Labor Costs Increase Higher-Than-Expected In Q2 ↗
U.S. stocks traded mixed this morning, with the Nasdaq dropping around 90 points on Tuesday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
  
Via Benzinga
News headline image
Quanterix: Q2 Earnings Insights ↗
  Quanterix (NASDAQ:QTRX) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Quanterix Announces the Resignation of Kevin Hrusovsky as Executive Chairman of Board of Directors
From Quanterix Corporation
Via Business Wire
News headline image
Recap: Quanterix Q4 Earnings ↗
Quanterix (NASDAQ:QTRX) reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
Earnings Scheduled For March 1, 2022 ↗
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
News headline image
Quanterix Corporation Releases Operating Results for Second Quarter 2022, Announces Business Re-Alignment Plan and Revises 2022 Guidance
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Participate in the Canaccord Genuity 42nd Annual Growth Conference
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix’ Second Quarter 2022 Earnings Conference Call
From Quanterix Corporation
Via Business Wire
News headline image
Earnings Scheduled For August 8, 2022 ↗
Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. 
Via Benzinga
News headline image
Quanterix Launches First pTau-181 Plasma Laboratory Developed Test for Clinical Diagnostic and Research Applications in the U.S.
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix's Return On Capital Employed Overview ↗
According to Benzinga Pro data, during Q1, Quanterix (NASDAQ:QTRX) posted sales of $29.55 million. Earnings were up 9.35%, but Quanterix still reported an overall loss of $18.15 million. 
Via Benzinga
News headline image
Quanterix to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Announces Appointment of Karen A. Flynn to Board of Directors
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Corporation Releases Operating Results for First Quarter 2022
From Quanterix Corporation
Via Business Wire
News headline image
Earnings Preview For Quanterix ↗
Quanterix (NASDAQ:QTRX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Quanterix will... 
Via Benzinga
News headline image
Quanterix Corporation to Release First Quarter 2022 Financial Results on May 10, 2022
From Quanterix Corporation
Via Business Wire
News headline image
Earnings Scheduled For May 10, 2022 ↗
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. 
Via Benzinga
News headline image
Quanterix Receives FDA Breakthrough Device Tag For NfL Test For Multiple Sclerosis ↗
Quanterix Corp (NASDAQ: QTRX) received FDA breakthrough device designation for multiple sclerosis (MS) diagnostic. Quanterix designed its Simoa neurofilament light... 
Via Benzinga
News headline image
Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis
From Quanterix Corporation
Via Business Wire
News headline image
What 4 Analyst Ratings Have To Say About Quanterix ↗
Over the past 3 months, 4 analysts have published their opinion on Quanterix (NASDAQ:QTRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Quanterix’ Simoa® Technology Powers Large, International Comprehensive Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Disease Activity in Multiple Sclerosis (MS) Patients
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Receives Funding from the Alzheimer’s Drug Discovery Foundation to Accelerate Alzheimer’s Disease Diagnostic Plasma Test Development
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix's Return On Capital Employed Insights ↗
Quanterix (NASDAQ:QTRX) brought in sales totaling $30.29 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 27.87%, resulting in a loss of $... 
Via Benzinga
News headline image
Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
From Quanterix Corporation
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2022 ↗
Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth... 
Via Benzinga
News headline image
Quanterix to Participate in the SVB Leerink Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
News headline image
UK Dementia Research Institute Biomarker Factory Powers Alzheimer’s Disease Breakthroughs with Quanterix Simoa® Technology
From Quanterix Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.